Search research articles
Contact Us
Filters
Showing results (281-290 of 386) with videos related to
Page
of 39
Sort By:
The Journal of Biological Chemistry
|
August 21, 2016
Histone deacetylase inhibitors activate NF-κB in human leukemia cells through an ATM/NEMO-related pathway
Roberto R Rosato, Sarah S Kolla, Stefanie K Hock, et al.
Plos One
|
September 3, 2014
Inhibition of the MDM2 E3 Ligase induces apoptosis and autophagy in wild-type and mutant p53 models of multiple myeloma, and acts synergistically with ABT-737
Dongmin Gu, Shuhong Wang, Isere Kuiatse, et al.
Journal of Gastroenterology and Hepatology
|
March 26, 2003
Regulation of p21 and p27 expression by the hepatitis B virus X protein and the alternate initiation site X proteins, AUG2 and AUG3
J Kevin Leach, Liang Qiao, Youwen Fang, et al.
Molecular Cancer Therapeutics
|
May 6, 2010
17-allylamino-17-demethoxygeldanamycin and MEK1/2 inhibitors kill GI tumor cells via Ca2+-dependent suppression of GRP78/BiP and induction of ceramide and reactive oxygen species
Teneille Walker, Clint Mitchell, Margaret A Park, et al.
Cancer Biology & Therapy
|
March 12, 2009
Historical perspective and recent insights into our understanding of the molecular and biochemical basis of the antitumor properties of mda-7/IL-24
Luni Emdad, Irina V Lebedeva, Zhao-zhong Su, et al.
Molecular Pharmacology
|
December 20, 2013
Phosphodiesterase 5 inhibitors enhance chemotherapy killing in gastrointestinal/genitourinary cancer cells
Laurence Booth, Jane L Roberts, Nichola Cruickshanks, et al.
Molecular Cancer Therapeutics
|
September 16, 2008
Mitogen-activated protein kinase kinase 1/2 inhibitors and 17-allylamino-17-demethoxygeldanamycin synergize to kill human gastrointestinal tumor cells in vitro via suppression of c-FLIP-s levels and activation of CD95
Margaret A Park, Guo Zhang, Clint Mitchell, et al.
Cancer Research
|
April 3, 2004
The histone deacetylase inhibitor MS-275 interacts synergistically with fludarabine to induce apoptosis in human leukemia cells
Sonia C Maggio, Roberto R Rosato, Lora B Kramer, et al.
Autophagy
|
August 5, 2011
Sorafenib enhances pemetrexed cytotoxicity through an autophagy-dependent mechanism in cancer cells
M Danielle Bareford, Hossein A Hamed, Yong Tang, et al.
Epigenomics
|
November 8, 2012
A focus on the preclinical development and clinical status of the histone deacetylase inhibitor, romidepsin (depsipeptide, Istodax(®))
Simon J Harrison, Mark Bishton, Susan E Bates, et al.
Page
of 39
Search research articles
Search
Showing results (281-290 of 386) with videos related to
Sort By:
Page
of 39
The Journal of Biological Chemistry
|
August 21, 2016
Histone deacetylase inhibitors activate NF-κB in human leukemia cells through an ATM/NEMO-related pathway
Roberto R Rosato, Sarah S Kolla, Stefanie K Hock, et al.
Plos One
|
September 3, 2014
Inhibition of the MDM2 E3 Ligase induces apoptosis and autophagy in wild-type and mutant p53 models of multiple myeloma, and acts synergistically with ABT-737
Dongmin Gu, Shuhong Wang, Isere Kuiatse, et al.
Journal of Gastroenterology and Hepatology
|
March 26, 2003
Regulation of p21 and p27 expression by the hepatitis B virus X protein and the alternate initiation site X proteins, AUG2 and AUG3
J Kevin Leach, Liang Qiao, Youwen Fang, et al.
Molecular Cancer Therapeutics
|
May 6, 2010
17-allylamino-17-demethoxygeldanamycin and MEK1/2 inhibitors kill GI tumor cells via Ca2+-dependent suppression of GRP78/BiP and induction of ceramide and reactive oxygen species
Teneille Walker, Clint Mitchell, Margaret A Park, et al.
Cancer Biology & Therapy
|
March 12, 2009
Historical perspective and recent insights into our understanding of the molecular and biochemical basis of the antitumor properties of mda-7/IL-24
Luni Emdad, Irina V Lebedeva, Zhao-zhong Su, et al.
Molecular Pharmacology
|
December 20, 2013
Phosphodiesterase 5 inhibitors enhance chemotherapy killing in gastrointestinal/genitourinary cancer cells
Laurence Booth, Jane L Roberts, Nichola Cruickshanks, et al.
Molecular Cancer Therapeutics
|
September 16, 2008
Mitogen-activated protein kinase kinase 1/2 inhibitors and 17-allylamino-17-demethoxygeldanamycin synergize to kill human gastrointestinal tumor cells in vitro via suppression of c-FLIP-s levels and activation of CD95
Margaret A Park, Guo Zhang, Clint Mitchell, et al.
Cancer Research
|
April 3, 2004
The histone deacetylase inhibitor MS-275 interacts synergistically with fludarabine to induce apoptosis in human leukemia cells
Sonia C Maggio, Roberto R Rosato, Lora B Kramer, et al.
Autophagy
|
August 5, 2011
Sorafenib enhances pemetrexed cytotoxicity through an autophagy-dependent mechanism in cancer cells
M Danielle Bareford, Hossein A Hamed, Yong Tang, et al.
Epigenomics
|
November 8, 2012
A focus on the preclinical development and clinical status of the histone deacetylase inhibitor, romidepsin (depsipeptide, Istodax(®))
Simon J Harrison, Mark Bishton, Susan E Bates, et al.
Page
of 39